Clinical Trials Logo

Clinical Trial Summary

Adverse drug reactions are an important public health consern that affects physician prescriptions and practice. The responsibilities of healthcare professionals in monitoring, prevention, treatment and reporting of drug hypersensitivity reactions and drug allergies are essential for patient safety. Providing drug safety must be one of the main goals to be achieved for every member of our society. In our study, we planned to evaluate the knowledge, attitudes, and behaviors of healthcare workers in our country about drug hypersensitivity reactions in pediatric patients and to determine the risk factors that may affect them.


Clinical Trial Description

This study was carried out in a capital-located university hospital with a capacity of 1150 beds. Healthcare workers who are authorized to intervene in children (0-18 age group) including medical doctors, nurses and dentists were enrolled to study. In the evaluation of the knowledge, attitudes, and behaviors of the participants about drug hypersensitivity reactions in children, a study questionnaire was developed by pediatric allergy and immunology specialists and pediatric nurses by considering the other studies on the same subject. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04252326
Study type Interventional
Source Saglik Bilimleri Universitesi
Contact
Status Completed
Phase N/A
Start date January 1, 2020
Completion date March 1, 2020

See also
  Status Clinical Trial Phase
Completed NCT02239237 - Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Completed NCT02191358 - YouScript IMPACT Registry N/A
Recruiting NCT04743544 - Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
Recruiting NCT04547335 - The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
Completed NCT02378220 - Pharmacogenetic Testing Among Home Health Patients N/A
Completed NCT01467128 - Adverse Drug Event Prevention Using Structured Pharmacist Review Phase 4
Completed NCT01354730 - A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women Phase 4
Recruiting NCT04496024 - Ofloxacin Concentration-toxicity Relationship in the Elderly N/A
Completed NCT02097654 - Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons N/A
Completed NCT01764204 - Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years N/A
Completed NCT04279470 - Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
Recruiting NCT03640884 - Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study
Completed NCT02122965 - The Effect of Medication Review in High-risk Emergency Department Patients N/A
Active, not recruiting NCT06456086 - Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions
Completed NCT01058122 - Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward
Recruiting NCT04479553 - Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.